
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review
J Schulz, David M. Stresser, J. Cory Kalvass
Drug Metabolism Reviews (2023) Vol. 55, Iss. 3, pp. 205-238
Closed Access | Times Cited: 21
J Schulz, David M. Stresser, J. Cory Kalvass
Drug Metabolism Reviews (2023) Vol. 55, Iss. 3, pp. 205-238
Closed Access | Times Cited: 21
Showing 21 citing articles:
Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake
Zhengyin Yan, Li Ma, Nicky Hwang, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 548-554
Open Access | Times Cited: 4
Zhengyin Yan, Li Ma, Nicky Hwang, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 548-554
Open Access | Times Cited: 4
A Sequential Ultrafiltration Method to Enhance the Accuracy and Throughput in Plasma Protein Binding Tests
S. Jeon, Min Chang Kim, Haejun Lee, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 273-273
Open Access
S. Jeon, Min Chang Kim, Haejun Lee, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 273-273
Open Access
Interpretation of Protein-Mediated Uptake of Statins by Hepatocytes Is Confounded by the Residual Statin-Protein Complex
Mengyue Yin, Kazuya Ishida, Xiaomin Liang, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1381-1390
Closed Access | Times Cited: 10
Mengyue Yin, Kazuya Ishida, Xiaomin Liang, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1381-1390
Closed Access | Times Cited: 10
Survey of Pharmaceutical Industry’s Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group
Helen Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 7, pp. 582-596
Open Access | Times Cited: 3
Helen Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 7, pp. 582-596
Open Access | Times Cited: 3
Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance
Shawn Pei Feng Tan, Annika Tillmann, Susan Murby, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4603-4617
Open Access | Times Cited: 3
Shawn Pei Feng Tan, Annika Tillmann, Susan Murby, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4603-4617
Open Access | Times Cited: 3
Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules
Markus Trunzer, Joana Teigão, Felix Huth, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 5, pp. 345-354
Open Access | Times Cited: 2
Markus Trunzer, Joana Teigão, Felix Huth, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 5, pp. 345-354
Open Access | Times Cited: 2
Lipophilic Group-Modified Manganese(II)-Based Contrast Agents for Vascular and Hepatobiliary Magnetic Resonance Imaging
Zhongyuan Cai, Lingling Jiang, Yingzi Cao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 5011-5031
Closed Access | Times Cited: 2
Zhongyuan Cai, Lingling Jiang, Yingzi Cao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 5011-5031
Closed Access | Times Cited: 2
Conquering the beyond Rule of Five Space with an Optimized High-Throughput Caco-2 Assay to Close Gaps in Absorption Prediction
Patricia Muschong, Khader Awwad, Edward Price, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 846-846
Open Access | Times Cited: 2
Patricia Muschong, Khader Awwad, Edward Price, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 846-846
Open Access | Times Cited: 2
Predicting clearance with simple and permeability-limited PBPK frameworks: comparison of well-stirred, dispersion and parallel tube liver models.
Swati Nagar, Rachel Parise, Ken Korzekwa
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 10, pp. 1060-1072
Closed Access | Times Cited: 2
Swati Nagar, Rachel Parise, Ken Korzekwa
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 10, pp. 1060-1072
Closed Access | Times Cited: 2
Hepatocyte Uptake and Loss Assay (HUpLA):Proof-of-Concept ofan All-in-One System for Measuring Hepatic Influx, Egress, and Metabolic Clearance Based on the Extended Clearance Concept
J Schulz, Elizabeth Sande, Mei Feng, et al.
Drug Metabolism and Disposition (2024), pp. DMD-001768
Open Access | Times Cited: 1
J Schulz, Elizabeth Sande, Mei Feng, et al.
Drug Metabolism and Disposition (2024), pp. DMD-001768
Open Access | Times Cited: 1
First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics
Patrick Poulin
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2641-2650
Closed Access | Times Cited: 1
Patrick Poulin
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2641-2650
Closed Access | Times Cited: 1
How predictive are isolated perfused liver data of in vivo hepatic clearance? A meta-analysis of isolated perfused rat liver data
J Schulz, J. Cory Kalvass
Xenobiotica (2024) Vol. 54, Iss. 9, pp. 658-669
Closed Access | Times Cited: 1
J Schulz, J. Cory Kalvass
Xenobiotica (2024) Vol. 54, Iss. 9, pp. 658-669
Closed Access | Times Cited: 1
Organic anion transporting polypeptides (OATPs/SLCOs): Pharmacology, toxicology, structure, and transport mechanisms
Bruno Hagenbuch, Bruno Stieger, Kaspar P. Locher
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100023-100023
Closed Access | Times Cited: 1
Bruno Hagenbuch, Bruno Stieger, Kaspar P. Locher
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100023-100023
Closed Access | Times Cited: 1
Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance
J Schulz, Jin Wang, Colin Phipps, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 1046-1052
Open Access | Times Cited: 2
J Schulz, Jin Wang, Colin Phipps, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 1046-1052
Open Access | Times Cited: 2
Novel method of measurement of in vitro drug uptake in OATP1B3 overexpressing cells in the presence of dextran
Anna Kowal-Chwast, Ewelina Gabor-Worwa, Nilesh Gaud, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 400-415
Closed Access
Anna Kowal-Chwast, Ewelina Gabor-Worwa, Nilesh Gaud, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 400-415
Closed Access
An Overview of Interpretability of Two Models of Unbound Fraction that are Used in Combination with the Well-Stirred Model for Predicting Hepatic Clearance of Drugs
Patrick Poulin
Journal of Pharmaceutical Sciences (2024)
Closed Access
Patrick Poulin
Journal of Pharmaceutical Sciences (2024)
Closed Access
The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends
John P. Savaryn, Kevin J. Coe, Matthew A. Cerny, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 11, pp. 2079-2093
Open Access
John P. Savaryn, Kevin J. Coe, Matthew A. Cerny, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 11, pp. 2079-2093
Open Access
Drug Metabolism & Disposition Clearance prediction with three novel plated human hepatocyte models compared to conventional suspension assays: Assessment with 50 compounds and multiple donors
David A. Kukla, J Schulz, Paul R Lesniak, et al.
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 2, pp. 100032-100032
Closed Access
David A. Kukla, J Schulz, Paul R Lesniak, et al.
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 2, pp. 100032-100032
Closed Access
Rat PermQ: A permeability-and perfusion-based PBPK model for improved prediction of drug concentration-time profiles in rat
Yifan Gong, Ken Korzekwa, Swati Nagar
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 2, pp. 100033-100033
Closed Access
Yifan Gong, Ken Korzekwa, Swati Nagar
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 2, pp. 100033-100033
Closed Access
Brain endothelial permeability, transport, and flow assessed over 10 orders of magnitude using the in situ brain perfusion technique
Quentin R. Smith, Haritha Mandula, Jagan Mohan R. Parepally, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access
Quentin R. Smith, Haritha Mandula, Jagan Mohan R. Parepally, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access
Absorption, Distribution, Metabolism, and Excretion of [14C]BS1801, a Selenium-Containing Drug Candidate, in Rats
Cheng Yang, Mingzhen Xue, Yifei He, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8102-8102
Open Access | Times Cited: 1
Cheng Yang, Mingzhen Xue, Yifei He, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8102-8102
Open Access | Times Cited: 1